Literature DB >> 16936213

New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.

Jacek Bochenski1, Grzegorz Placha, Krzysztof Wanic, Maciej Malecki, Jacek Sieradzki, James H Warram, Andrzej S Krolewski.   

Abstract

The K121Q polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is associated with type 2 diabetes and obesity. The possibility of other ENPP1 polymorphisms influencing these phenotypes has received little attention. Our aim was to examine the associations of tagging single nucleotide polymorphisms (SNPs) and haplotypes of the linkage disequilibrium (LD) block containing K121Q polymorphism with type 2 diabetes in a Polish population, controlling for any effect of obesity. We genotyped 426 type 2 diabetic case and 370 control subjects for seven SNPs in ENPP1. In the total group, neither type 2 diabetes nor obesity was significantly associated with any SNP. However, in obese subjects, two SNPs were significantly associated with type 2 diabetes: the Q allele of K121Q (odds ratio 1.6 [95% CI 1.003-2.6]) and T allele of rs997509 (4.7 [1.6-13.9]). In the LD block, four SNPs plus the K121Q polymorphism distinguished six haplotypes, three of which carried the Q allele. Interestingly, the T allele of rs997509 sufficed to distinguish a 121Q-carrying haplotype that was significantly more associated with type 2 diabetes than the other two (4.2 [1.3-13.5]). These other two 121Q-carrying haplotypes were not associated with type 2 diabetes. In conclusion, we found a new SNP, rs997509, in intron 1 that is strongly associated with risk of type 2 diabetes in obese individuals. The molecular mechanisms underlying this association are unknown.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936213     DOI: 10.2337/db06-0191

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

1.  Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

Authors:  Salvatore De Cosmo; Antonio Minenna; Yuan-Yuan Zhang; Ryan Thompson; Robert Thompson; Giuseppe Miscio; Monica Vedovato; Anna Rauseo; Alois Saller; Sandra Mastroianno; Fabio Pellegrini; Roberto Trevisan; Paola Fioretto; Alessandro Doria; Vincenzo Trischitta
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

Review 2.  Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.

Authors:  Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

Review 3.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?

Authors:  J C Florez
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

4.  Association of genetic variation in ENPP1 with obesity-related phenotypes.

Authors:  Christopher P Jenkinson; Dawn K Coletta; Marion Flechtner-Mors; Shirley L Hu; Marcel J Fourcaudot; Lenore M Rodriguez; Jennifer Schneider; Rector Arya; Michael P Stern; John Blangero; Ravindranath Duggirala; Ralph A DeFronzo
Journal:  Obesity (Silver Spring)       Date:  2008-05-08       Impact factor: 5.002

5.  Contribution of ENPP1, TCF7L2, and FTO polymorphisms to type 2 diabetes in mixed ancestry ethnic population of South Africa.

Authors:  Yandiswa Y Yako; Jabulisile H Madubedube; Andre P Kengne; Rajiv T Erasmus; Tahir S Pillay; Tandi E Matsha
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

Review 6.  Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Authors:  Sabrina Prudente; Eleonora Morini; Vincenzo Trischitta
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

7.  The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.

Authors:  Allan F Moore; Kathleen A Jablonski; Clinton C Mason; Jarred B McAteer; Richard F Arakaki; Barry J Goldstein; Steven E Kahn; Abbas E Kitabchi; Robert L Hanson; William C Knowler; Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2008-11-18       Impact factor: 5.958

Review 8.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

9.  Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population.

Authors:  Sinan Tanyolaç; Robert W Mahley; Uğur Hodoglugil; Ira D Goldfine
Journal:  Obesity (Silver Spring)       Date:  2008-08-21       Impact factor: 5.002

10.  Single locus and haplotype association of ENPP1 gene variants with the development of retinopathy among type 2 diabetic patients.

Authors:  Sahar Gohari-Lasaki; Alireza Sharafshah; Saima Abbaspour; Parvaneh Keshavarz
Journal:  Int Ophthalmol       Date:  2020-01-04       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.